This is a list of adverse effects of the anti-cancer drug pazopanib, sorted by frequency of occurrence.
Very common Very common (>10% incidence) adverse effects include:
Common Common (1–10% incidence) adverse effects include:
Uncommon Uncommon (0.1–1% incidence) adverse effects include:
Rare Rare (<0.1% incidence) adverse effects include:
Reversible posterior leukoencephalopathy syndrome
Notes † Denotes side effects seen at the above frequency only in clinical trials performed in people with renal cell carcinoma. ‡ Denotes side effects seen at the above frequency only in clinical trials done in people with soft tissue sarcomas.
References
